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The report of an imaging procedure is a critical component of an examination, being the final and often the only communication from the
interpreting physician to the referring or treating physician. Very limited evidence and few recommendations or guidelines on reporting
imaging studies are available; therefore, an European position statement on how to report nuclear cardiology might be useful. The current
paper combines the limited existing evidence with expert consensus, previously published recommendations as well as current clinical
practices. For all the applications discussed in this paper (myocardial perfusion, viability, innervation, and function as acquired by single
photon emission computed tomography and positron emission tomography or hybrid imaging), headings cover laboratory and patient
demographics, clinical indication, tracer administration and image acquisition, findings, and conclusion of the report. The statement
also discusses recommended terminology in nuclear cardiology, image display, and preliminary reports. It is hoped that this statement
may lead to more attention to create well-written and standardized nuclear cardiology reports and eventually lead to improved clinical
outcome.
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Preamble
This positionpaperon reporting nuclear cardiologyexaminationshas
been developed under the auspices of the Cardiovascular Commit-
tee of the European Association of Nuclear Medicine (EANM) and
the Section on Nuclear Cardiology and Cardiac Computed Tomog-
raphy of the European Association of Cardiovascular Imaging
(EACVI) of the European Society of Cardiology (ESC), highlighting
the importance for close collaboration and bridging between the
two specialties.
In the daily routine, this collaboration is particularly obvious in two
areas: referral for the nuclear cardiology examination and the com-
munication of the outcome of the examination. The former has
more recently received a lot of attention with discussions of appro-
priate use criteria, classes of indications of the examinations, and
varying reimbursement in some European countries, etc. In contrast,
the communication of the results has received much less attention,
though of equal significance. It is therefore important that, by
reading the report, the results of the examination are understood
as closely and accurately as possible reflecting the interpretation of
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the nuclear medicine physician. Ideally, the information presented
should be uniform and independent of individual physician’s prefer-
ences or patient-specific parameters.
The information presented below is specifically adapted to Euro-
pean practice. A significant limitation of our recommendations is
the lack of evidence from original scientific studies on the influence
of the report on the use of the results of the examination. Another
important limitation for the present, English written, paper is related
to the great variationswithin Europeboth regarding national traditions
and regulations, and thedifferences in the languages.With those limita-
tions, the authors wish to give some recommendations regarding
structure and standards for the nuclear cardiology report: the goal
of the report must be to transfer from the interpreting physician to
the referring physician a message that in a coherent clinically relevant
and predictable format1 and in an easily readable way that concisely
reflects the nuclear medicine interpretation of the examination.
Introduction
‘The report of an imaging procedure is often the only communication
from the interpreting physician to the caregiver, and is the final
and perhaps the most critical component of an imaging procedure’.1
Itmayoccasionally alsomay become legal evidence.2 In away, nuclear
cardiology studies undergo two interpretations: the first one being
performed by the physicians who make a report based on the ana-
lyses and interpretation of the images, stress data, etc. The second
is the interpretation made by the physician who reads the report
and from this reading draws his or her conclusions for further clinical
action. Although sometimes the referring and image report making
person are the same, the information in the report should be uniform
andas accurately possible reflecting the interpretation.Guidelineson
reporting imaging procedures in nuclear cardiology, to optimize the
communication of the information from reporter to reader, are
essential.
Ideally, guidelines should be based on evidence from clinical
studies,3 but in practice mostly on expert opinions. Owing to a lack
of published evidence, all available recommendations on reporting
nuclear cardiology are largely or totally based on expert opinions.
Fortunately, there iswide consensus onmostof the issues,4–6 includ-
ing the critical need of structured reporting, as opposed to free text
descriptions, so that key report components and data elements are
not omitted. Increased standardization would facilitate the reading
of reports.1 Terminology must be accurate, but always expressed
in a reader friendly style.
Thepresentpapercombines existingevidencewith expertopinions
and previously published guidelines and recommendations1,4–11 with
current clinical practices. This joint expert statement focuses on:
(i) Myocardial perfusion imaging (MPI)with single photon emission
computed tomography (SPECT) or positron emission tomog-
raphy (PET).
(ii) Equilibrium radionuclide ventriculography (ERNV).
(iii) Viability imaging evaluated by 18F-fluoro-deoxyglucose (FDG)
PET/MPI.
(iv) Hybrid imagingwithcoronaryartery calciumscore (CACS) and/
or coronary CT angiography (CCTA) and MPI.
(v) 123I-metaiodobenzylguanidine (MIBG) imaging.
The paper also includes discussion of terminology, use of preliminary
reports, and the selectionof images accompanying the report. In con-
cordance with the previously published guidelines,10 three levels of
importance are used, including ‘must’ (information required in the
report), ‘should’ (information highly recommended), and ‘may’
(optional information).
The minimum information recommended to be included in the
report appears as ‘must’ and encompasses unequivocal identifica-
tion of patient, study, date, and signature (often digital), as well as a
description of findings, whether normal, abnormal or inconclusive,
and finally a conclusion presenting the clinical interpretation of the
findings. The remaining data that can be added in the report
dependonanumberof factors, including national and local traditions
and ‘culture’, national legislation, and relation between the referring
and reporting physicians and/or institutions. Examples of reports are
presented that include both ‘must’ and ‘should’ information to
present the level recommended by the authors, i.e. in-between
the minimum (‘must’) and, ‘may’ be included information. Reports
must include sufficient data of relevant detailed elements to describe
the findings, but too lengthy reports should be avoided. Compared
with US guidelines,1,10 those presented in this statement allow
for more degrees of freedom, which is related to European vs. US
traditions, the national variations within European countries, and
possibly also related to themorecommonuseofmedical legal litigat-
ing in theUSAand thereby the relatedover-completeness/defensive
medicine.
It is hoped this papermay lead to improvement in the clinical value
of nuclear cardiology for patients and physicians aswell as to facilitate
and improve research in nuclear cardiology.12 However, recommen-
dationspresented areneither infallible nor substitute for goodclinical
judgment.
Terminology in the report
It is crucial that the referring or treating physician understands the
report as intended by the interpreter of the images. This implies
careful attention to the terminology used in the report.
Regarding general language, it is strongly recommended that:
(i) The report iswritten in a simpleway, if possible, without the use
of technical terms.
(ii) The use of abbreviations and technical information not import-
ant for the referring physician should be avoided or extremely
limited.
(iii) Qualitative descriptions (e.g. small, medium-sized, large or
slightly, moderately, severely reduced) should be replaced, if
possible, by quantified data since qualitative words are used
and understood differently.13
(iv) Protective expressions (e.g. is likely, cannot be excluded)
are used as little as possible. However, relevant doubt
about the clinical implication of the interpretation must be
communicated.
The report must cover clinically relevant information, but not
technically irrelevant details. Terms should be used that are widely
recognized and approved both in nuclearmedicine and in cardiology.
The section on findingsmust give a precise description of the images.
Someexpressionsmayappearequally good: aperfusiondefect canbe
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reversible (stress-induced) or irreversible (non-reversible, fixed, and
permanent). Depending on the context, one expression may appear
more correct than another one. In the description of SPECT findings,
an ischaemic perfusion defect is less accurate than a reversible or
stress-induced perfusion defect, but is more relevant in the clinical
conclusion of the study. Likewise, in the conclusion, an expression like
a fixedor permanent perfusion defect, relevant in the section on find-
ings, should be translated to infarction or scar tissue, provided that
viable tissue is unlikely. The more standardized format of accurate
and relevant information is provided, the better the reader’s inter-
pretation will be minimizing misunderstandings of the report
leading to subsequent better clinical decisions.
The preliminary report
In communicationsother than thefinal report, thepreliminary report
is the most important type of message given about an imaging study.
Preliminary reports, typically given in order to direct immediate
patient management, may be written, transmitted electronically, or
given verbally. It is not expected to include all information of the
final report.14 The person responsible for the preliminary communi-
cationmust assure the receipt of it. The preliminary report should be
reproduced into a permanent format and archived as a preliminary
communication, since clinical decisions may very well be based on
a preliminary report. Subsequently, it must be documented in the
final report. The documentation is important, as recently shown
for pulmonary scintigraphy.15 If it has been given as a person-to-
person communication, it must specifically name the person to
whom the communication was delivered. If the message of the final
report deviates from that of the preliminary report, this discrepancy
should be clearly stated in the final report. Immediate transfer of a
preliminary report has been shown in radiology to result in a small,
but important number of adverse outcomes. However, if edited in
the final report, the benefits of rapid information transmission may
outweigh the additional risks.16
Oral communications
Sometimes other forms of communication may occur, e.g. during a
clinical conference or by a verbal comment to an outside study. Occa-
sionally, such an interpretation does not result in a ‘formal’ report.
That typeof communication carries an inherent riskbymissing compari-
sonwith previous studies, adequate patient history, etc., and is therefore
not recommended. Ideally, discussion in multidisciplinary meetings (i.e.
more than one medical specialty present) and the subsequent clinical
decisions should be reported in a separate report.
The structured nuclear cardiology
report
A structured report, in contrast to free text, with adequate headings
should be used, since a well-structured report is more easily access-
ible for the referring or treating physician.1,4 In the present paper, a
number of headings have been used to describe the different
aspects of the report. They were chosen since they are widely used
in clinical imaging practice and recommended for nuclear cardiology
by others as well.7,9 Headings may differ between different institu-
tions and different countries due to local tradition and legislation.
The headings used here include: demographics; clinical indication;
tracer administration and image acquisition; findings; conclusion; as
well as date and signature. Figures 1 and 2 show examples of
Figure 1 Example of the contents that should (including must) be provided in a report of a normal MPI.
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reports from a normal and from an abnormal MPI, with information
that ‘should’ (including ‘must’) be included in the report.
Demographics
Site administrative data (physical address), contact information, as
well as name and affiliation of the referring physician must be pro-
vided, as well as patient name, unique identification number (date
of birth, etc.), and gender.
Clinical indication(s)
The clinical indication for the study should be reported, both to
show the appropriateness of the study and to focus the examination
and the report. Cardiac history and symptoms and prior cardiac
investigations may be summarized, active medications may be
noted, and pre-test probability of coronary artery disease may be
calculated.
Tracer administration
The tracer administered and amount of radioactivity should be
reported. According to legislation in some countries, the amount
of radioactivity must be reported. For 99mTc-labelled tracers, it
should be noted if a 1-day or a 2-day protocol is followed. The
timing in relation to termination of a stress test procedure and the
time interval between tracer injection and image acquisition should
be noted.
For an FDGstudy, blood glucose at the timeof FDG injectionmust
be reported in diabetic patients; in other patients, it may be noted.
Oral glucose load, insulin–glucose clamp, acipimox administration
etc., must also be reported.
Image acquisition
If the routine procedure is followed, it should not be described in the
report. If thedefault procedure has notbeen chosen, the reasonmust
be presented, e.g. changes from the usual protocol regarding rota-
tion, position of patient, gating, or attenuation/scatter correction
problems, etc.
Findings
Myocardial perfusion imaging
The stress testing procedure and findings must be briefly described,
also if the stress test is normal (Table 1). The perfusion distribution is
the key information:Does the activity distribution in themyocardium
appear normal, abnormal only at stress or also at rest, or is the study
non-diagnostic? The findings should be described as shown in Table 2.
Figure 2 Example of the contents that should (including must) be provided in a report of an abnormal MPI.
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Left ventricular function
If gated studies have been acquired (rest and/or stress), left ventricu-
lar (LV) function data should be reported, as also shown in Table 3.
Reference values of LV ejection fraction (EF) should accompany
the report, either as values from the department (preferable) or as
values referred from the literature obtained with similar technique
and software tools. Possible discrepancies between regional perfu-
sion and regional myocardial functional data must be discussed.
Equilibrium radionuclide ventriculography
LVEF must be presented (Table 4), and reference values of LVEF
should accompany the report, either as values from the department
(preferable) or as values referred from the literature obtained with
similar technique and software tools. It should be noted (cf. section
on reference values in ref. [8]) that LVEF values differ between men
and women and between gated MPI and ERNV.
Viability with FDG in combination with MPI (by PET or
SPECT)
Regional FDG uptake must be described in relation to reduced re-
gional perfusion (SPECT or PET): is FDG uptake reduced (match
between reduced metabolism and reduced perfusion), or is it
normal or enhanced (mismatch in relation to reduced regional perfu-
sion)? The evaluation compares the uptake in thehypoperfusedmyo-
cardial regionwith that in the remotemyocardium.Quantification of
mismatch is recommended.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Findings of tracer distribution in the report of a gated myocardial perfusion SPECT study
Tracer distribution Must be included Should be included May be included
Normal Brief description
Abnormal Presence of defect(s) Other comments to perfusion
distribution abnormalities
Location of defect(s) Relation to LV segments, relation to the
patient’s coronary artery distribution
if known
Preferably using the 17-segment model.9
Suggestion of single- or MV disease
Relation to standard coronary
anatomy with reservations
regarding anatomy variations
Extent of defect(s) Description of defect size(s). ‘Large’,
‘small’, etc. is a minimum
Quantification as percentage or a percentage
interval of the LVa; alternatively in summed
scores
Severity of defect(s) Description of defect severity. ‘Mild’,
‘severe’, etc. is a minimum
Quantified in summed stress/rest/difference
scoresb
Reversibility of
defect(s)
Reversible (stress-induced), fixed
(permanent and irreversible), or
mixed (partially reversible) defect(s)
Quantified in summed difference scoresb
Quantification of
regional perfusion
in PET
Absolute values in ml/min/g tissue at rest/
during hyperaemia, including reference
values. Coronary flow reserve in units
Other abnormalities Incidental extracardiac findings Deviations in tracer distribution (locally
increased/decreased uptake, LV cavity
dimensions)
Non-diagnostic study Describe the reason
LV, left ventricular; MV, multivessel.
aA reversible defect .10% of the LV has prognostic information.17,18
bScores vary with software systems used.19
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Findings related to the stress test in the report of an myocardial perfusion SPECT study
Stress test type Must be included Should be included May be included
Symptom limited
exercise test
Reason for termination of test Exercise capacity (MET), peak HR, and
BP, changes vs. rest.
Stress-induced symptoms and abnormal
ECG findings (rest and stress-induced)
Type of protocol: Bruce,
modified Bruce, etc.
Pharmacological
stress+ exercise
Vasodilators or dobutamine (+atropine).
Reason for premature termination.
Other drugs including doses administered
during the test (anti-anginal, etc.)
Doseof stress agent and timingof administration Symptoms and ECG
changes.
HR and BP baseline/peak
BP, blood pressure; HR, heart rate; METs, metabolic equivalents.
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Hybrid imaging with CACS and/or CCTA
The description of MPI is similar to the stand-alone study. The
additional information obtained from CACS or CCTA must be
reported and integrated with the MPI results. With CCTA, report-
ing should follow the recommendations of stand-alone CCTA, as
described in detail in part B of the guidelines of the Society of Car-
diovascular Computed Tomography.20 The severity of a stenosis
can be assessed in qualitative terms (minimal, mild, moderate,
severe, and occluded), or the length and luminal reduction may
be quantified. The location and severity of detected lesions must
be set in relation to the regional MPI findings, and a conclusion
drawn regarding agreement or disagreement between findings by
the two modalities. The clinical interpretation must be discussed
in case of a possible disagreement, e.g. is a stenosis detected by
CCTA hardly of haemodynamic significance since stress perfusion
is normal in that region; or could the perfusion findings be falsely
normal, maybe due to balanced ischaemia in multivessel coronary
disease? Further diagnostic examinations or invasive angiography
may be recommended.
123I-metaiodobenzylguanidine
Normal or reduced 123I-MIBG cardiac uptake must be described, and
comment on the clinical significance should be included (Table 5). If
available, possible perfusion/innervationmismatch shouldbediscussed.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Findings of LV function in the report of a gated myocardial perfusion SPECT study
LV function Must be included Should be included
LVEF Numerical values Reference values
LV volumes Numerical values (with reference values)
Presence of TID (visual evaluation and/or quantified)
WM Visual evaluation: normal, hypokinesia (mild, moderate, and severe),
akinesia, or dyskinesia
WT Visual evaluation: normal, decreased (mild, moderate, and severe),
or absent
Phase analysis Dyssynchrony
Differences between stress and rest global
and regional LV function
Stress-induced LV dilatation (TID) Comment on differences
Findings that may reduce the accuracy of
the assessment of LV function
Other comments (i.e. cardiac arrhythmias)
Local perfusion/WM orWT relationship A comment
Non-diagnostic study Describe the reason
LV, left ventricular; EF, ejection fraction; TID, transient ischaemic dilatation; WM, wall motion; WT, wall thickening.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 4 Findings in the report of an ERNV
Must be included Should be included May be included
LV functional evaluation
LVEF value Reference values, either as values from the department
(preferable) or as values referred from the literature
obtained with similar technique and software toolsa
Regional LV function and volumes, if relevant (e.g.
suspicion of ischaemic aetiology of a cardiomyopathy).
Description of a very dilated or a very small LV cavity in
qualitative terms.
An artificially high LVEF value (.70%) may be related
to a small LV
LVEF monitoring
Add comment on a significant
change for LVEF determination
(if applicable)
RV functionb
Presence of a large RV or tricuspid regurgitation into the
splanchnic area
ERNV, equilibrium radionuclide ventriculography; LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction.
aLVEF values differ between men and women and between gated myocardial perfusion SPECT and ERNV.
bRVEF can be determined accurately only from a tomographic ERNV or by a first-pass technique (not discussed in this paper).
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Conclusion of the report
The conclusionmust address and as clearly as possible answer the clin-
ical question from the indication. A statement must be given whether
the study is normal, abnormal, or inconclusive. Results from the
present studyshouldbecomparedwithprevious studies if available. In-
formation about technical errors, sub-optimal quality, or abnormal
extracardiac traceruptake shouldbementioned. Furtherdiagnostic in-
vestigationmay be suggested, dependent on the relationship between
the referring and interpreting physician and based on the extent and
severity of present perfusion and functional abnormalities.
For the different study types, specific points are presented in
Table 6.
Images in the report
Images accompanying the reportmust illustrate and support the con-
clusion. Care should be taken not to present images that may cast
doubt on the interpretation of the study (e.g. images with artefacts,
reported as normal). If not, they can be confusing or even lead tomis-
interpretation for the clinical reader of the report. Technical images
(a raw image from a screen capture of a cine loop, etc.) and text
(matrix, filter information, etc.) are superfluous and should not be
included. Several colour scales are available in current reporting
environments. It is important to use the same, standardized scale
for each type of study9 and to present a limited number of images
since the referring physician rarelywants to look at toomany images.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 5 Findings in the report of a cardiac 123I-MIBG study
Cardiac images Must be included Should be included May be included
Planar Visual description (normal, abnormal,
or non-diagnostic study)
Quantified in early and late H/M ratios and
washout rate, with reference to normal values
Prognostic information
SPECT Description of regional defects regarding location,
extent, and severity
Relation to perfusion when MPI is availablea
H/M, heart-to-mediastinum ratio.
aCf. Table 2 for the findings to include in the report regarding the gated MPI part of the study. 123I-MIBG uptake should follow the same nomenclature.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 6 Conclusions in the report of nuclear cardiology study types
Must be included Should be included May be included
Myocardial perfusion
SPECT
Defect suggesting stress-induced
ischaemia or scar tissue. Location
and extension/severity
Defect: Extent and severity quantified.
Relation of defect to coronary anatomy
and/or stenosis if reported/available
Functional data from gated
myocardial perfusion
SPECT
Stress and rest (if available) LVEF and
change from rest to stress.
Reference values for LVEF.
LV dilatation, TID.
Concordances and discrepancies
betweenperfusion andwallmotion,
if observed
LV volumes and regional function.
Synchrony
Other quantitative values
ERNV LVEF value with reference values.
Significant change from a previous
EF value
LV volumes Regional LV abnormalities
Viability imaging Viable or non-viable tissue.
Summary of the location and extent
of viable tissue (% of LV)
Extracardiac FDG accumulations LV function
Hybrid imaging Integration of both imaging modalities.
Otherwise similar to stand-alone
studies
Comparison between quantified
stenosis and quantified
stress-induced perfusion defect.
Integrated risk stratification
123I-MIBG Normal or reduced 123I-MIBG uptake.
Significantly abnormal H/M ratios
and/or washout rate.
Possible perfusion/innervation
mismatch
Prognostic information
(if relevant)
EF, ejection fraction; ERNV, equilibrium radionuclide ventriculography; FDG, 18F-fluoro-deoxyglucose; LV, left ventricular; TID, transient ischaemic dilatation.
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Gated MPI
Images showing both tomograms (stress and rest slices correctly
aligned) and polar plots are recommended. An image display has
beendiscussed in further detail in the Europeanprocedure guidelines
on myocardial perfusion.9
Equilibrium radionuclide
ventriculography
A printer/reader friendly screen capture can be used showing ‘best
septal’ separation of the LV in end-diastole and end-systole with
regions of interest superimposed (including background) with an
LV time/activity curve. Parametric amplitude and phase images (the
latter with its histogram) may be included.8
Viability imaging
Relevant slices or polar plot images (cf. above under MPI images)
showing perfusion and FDG images should be shown side by side,
correctly aligned.
Hybrid imaging
Perfusion images are displayed as discussed above.TheCCTA images
should be analysed and displayed according to the standardmethod-
ology for CCTA. Specific software tools for hybrid displays are cur-
rently not yet standardized. The general aim, however, is that the
perfusiondistribution is overlaidwith individual coronary vasculature
to allow precise localization of perfusion abnormalities with coron-
ary anatomy.
123I-MIBG cardiac imaging
Anterior, planar, early, and late images should be presented.21 In case
SPECT or PET images are presented, the display should follow the
same rules for slice presentation and polar plots as described for
MPI.9 Images showing ROIs may be added to show the quality of
quantified data.
Conclusion
Over the years, a lot has been done to achieve optimal data and
images by the best protocols, tracers, and cameras, and to
improve their interpretation by training and the use of sophisticated
hardware and software tools. However, little attention has been
paid to the transmission of the image information from the report-
ing physician to the referring physician: the creation of the good
report. Efforts must be made to improve the report by increased
standardization and by an appropriate written communication,
using simple, clinically relevant, and accurate terminology. In
general, the reports should be brief. Information that is of little
value for the referring physician should be omitted and the use of
protective expressions limited to the doubt in interpretation that
sometimes must be communicated.
The present joint paper may hopefully lead institutions and
teachers of nuclear cardiology to better recognize, underwrite, and
instruct the importance of a good report. In addition, this joint
expert statementmay trigger studieson theeffect of different report-
ing manners and systems on clinical decision-making, thereby
generating scientific evidence on this final, important component of
nuclear cardiology examinations.
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